AzTrials
AzTrials

Chronic PainDigiDOL-AdNCT06765200

Effectiveness of a Digital Treatment for Adolescents with Chronic Pain

A study testing Self-administered psychosocial intervention delivered via smartphone. in people with Chronic Pain, run by University Rovira i Virgili at 1 site in Spain.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Research has shown that the prevalence of chronic pain in adolescents is high and increasing. These young people report significant changes in both their physical and psychological functioning. Read more about this study

Who is it for?
Ages 12 to 18 years
Conditions the study is for
Chronic Pain
What is being tested?
Self-administered psychosocial intervention delivered via smartphone.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
195 participants
Where
1 siteSpain
Study dates
Oct 2025to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • 12-18 years old,
  • Having a non-oncology secondary chronic pain problem,
  • Having internet access,
  • A parent willing to participate in the study,
  • Providing informed consent/assent.

Who cannot join

  • Cognitive or language problems

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Spain1 site
  • Universitat Rovira i Virgili

    Tarragona

    Sampietro, +34 977 55 84 71, ariadna.sampietro@urv.cat

    Jordi Miró

Other trials in Spain

About this study

Research has shown that the prevalence of chronic pain in adolescents is high and increasing. These young people report significant changes in both their physical and psychological functioning. Currently, psychosocial treatments enjoy strong empirical support and are crucial to maintaining and improving the quality of life of adolescents suffering from chronic pain. However, the availability of these evidence-based interventions is insufficient to meet the high demand, especially outside of large cities. The aim of this project is to develop a digital treatment that helps improve the quality of life of adolescents with chronic pain and complementary websites for their parents and teachers.

Conditions
Chronic Pain
Being tested
Self-administered psychosocial intervention delivered via smartphone.
Keywords
chronic pain, mhealth, adolescent, mobile application
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-administered psychosocial intervention delivered via smartphone.Behavioural

    The treatment includes a smartphone-based psychosocial program designed to improve the quality of life of adolescents with chronic pain.

Study groups in NCT06765200
Study groupRoleWhat they receive
Digital treatmentExperimentalThe treatment includes a smartphone-based psychosocial program designed to improve the quality of life of adolescents with chronic pain.
Receives: Behavioral: Self-administered psychosocial intervention delivered via smartphone.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Refers to the severity of pain an individual experiences, measured on a scale (0-10)

    Measured: baseline, 8 weeks, 3 months follow-up

  2. Pain interference

    Refers to the extent to which pain affects an individual's daily life and functioning. Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Pain Interference will be used (0-32; 0=no interference, 32=intense interference).

    Measured: baseline, 8 weeks, 3 months follow-up

  3. Global perception of change after treatment

    refers to an individual's overall assessment of how their condition has improved or worsened following a treatment, measured on a scale (0-10).

    Measured: 8 weeks, 3 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2025
  2. Study startOct 2025 (estimated)
  3. Primary completionJul 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
195 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06765200
Sponsor's protocol ID
PID2022-142071OB-I00
Acronym
DigiDOL-Ad
Status last verified
Jan 2025
First submitted
19 Dec 2024
Last updated
9 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Miro J, Sampietro A, Monterde S, Ingelmo P, Wicksell RK, Nolla C, Alonso M, Lazaro JJ, Martinez E, Rubio P, Sanchez A, Sanchez V, Vazquez A, de la Vega R, Reinoso-Barbero F. Development, implementation and evaluation of a digital treatment for adolescents with chronic pain: a protocol for a multi-phase study. Front Digit Health. 2025 Jun 4;7:1555733. doi: 10.3389/fdgth.2025.1555733. eCollection 2025.

    PubMed 40534825

Questions about this trial

What is this clinical trial studying?

A study testing Self-administered psychosocial intervention delivered via smartphone. in people with Chronic Pain, run by University Rovira i Virgili at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ariadna Sampietro (+34 977558471, ariadna.sampietro@urv.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: baseline, 8 weeks, 3 months follow-up). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06765200, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in